购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

PHA-793887

Rating icon 很棒
产品编号 T2113Cas号 718630-59-2
别名 PHA793887, PHA 793887

PHA-793887 是一种ATP 竞争性的CDK 抑制剂,可抑制 Cdk2、Cdk1、Cdk4 和 Cdk9 的活性,IC50值分别为 8 nM、60 nM、62 nM 和 138 nM,同时可抑制糖原合酶激酶 3β,IC50值为 79 nM。

PHA-793887
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

PHA-793887

Rating icon 很棒
纯度: 100%
产品编号 T2113 别名 PHA793887, PHA 793887Cas号 718630-59-2

PHA-793887 是一种ATP 竞争性的CDK 抑制剂,可抑制 Cdk2、Cdk1、Cdk4 和 Cdk9 的活性,IC50值分别为 8 nM、60 nM、62 nM 和 138 nM,同时可抑制糖原合酶激酶 3β,IC50值为 79 nM。

规格价格库存数量
1 mg¥ 289现货
2 mg¥ 413现货
5 mg¥ 745现货
10 mg¥ 1,180现货
25 mg¥ 2,250现货
50 mg¥ 3,580现货
100 mg¥ 5,130现货
1 mL x 10 mM (in DMSO)¥ 592现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"PHA-793887"的相关化合物库

选择批次:
纯度:99.19%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
PHA-793887 has been used in trials studying the treatment of Advanced/Metastatic Solid Tumors.
靶点活性
CDK2-CyclinE:8 nM, CDK5-p25:5 nM, CDK1-CyclinB:60 nM, CDK7-CyclinH:10 nM, CDK2-CyclinA:8 nM
体外活性
20 mg/kg PHA-793887对携带K562和HL60细胞的移植瘤模型,原代白血病扩散细胞模型和复发Philadelphia-阳性急性淋巴性白血病患者高负荷播散性ALL-2模型有效.PHA-793887(10-30 mg/kg)在人卵巢A2780,结肠HCT-116和胰腺BX-PC3癌异种移植模型中显示出良好的功效.
体内活性
PHA-793887诱导细胞周期停滞,抑制Rb和核磷酸磷酸化,0.2-1 μM时调节细胞周期蛋白E和cdc6表达,5 μM时诱导凋亡。PHA-793887对白血病细胞系(包括K562,KU812,KCL22和TOM1)具有细胞毒性,IC50为0.3-7 μM,但对正常未刺激的外周血单个核细胞或CD34 +造血干细胞没有细胞毒性。PHA-793887作用于白血病细胞系具有高活性,IC50< 0.1 μM。 PHA-793887抑制许多肿瘤细胞系(包括A2780,HCT-116,COLO-205,C-433,DU-145,A375,PC3,MCF-7和BX-PC3)的细胞增殖,IC50为88 nM- 3.4 μM。
激酶实验
CDK Kinase Assay: The biochemical activity of compounds is determined by incubation with specific enzymes and substrates, followed by quantitation of the phosphorylated product. PHA-793887 (1.5 nM–10 μM) is incubated for 30?90 min at room temperature in the presence of ATP/33P-γ-ATP mix, substrate, and the specific enzyme (0.7?100 nM) in a final volume of 30 μL of kinase buffer, using 96 U bottom plates. After incubation, the reaction is stopped and the phosphorylated substrate is separated from nonincorporated radioactive ATP using SPA beads, Dowex resin, or Multiscreen phosphocellulose filter as follows: (1) For SPA Assays. The reaction is stopped by the addition of 100 μL of PBS + 32 mM EDTA + 0.1% Triton X-100 + 500 μM ATP, containing 1 mg of streptavidin-coated SPA beads. After 20 min of incubation for substrate capture, 100 μL of the reaction mixture is transferred into Optiplate 96-well plates containing 100 μL of 5 M CsCl, left to stand for 4 hours to allow stratification of beads to the top of the plate, and counted using TopCount to measure substrate-incorporated phosphate. (2) For Dowex Resin Assay. An amount of 150 μL of resin/formate, pH 3.00, is added to stop the reaction and capture unreacted 33P-γ-ATP, separating it from the phosphorylated substrate in solution. After 60 min of rest, 50 μL of supernatant is transferred to Optiplate 96-well plates. After the additon of 150 μL of Microscint 40, the radioactivity is counted in the TopCount. (3) For Multiscreen Assay. The reaction is stopped with the addition of 10 μL of EDTA (150 mM). An amount of 100 μL is transferred to a MultiScreen plate to allow substrate binding to phosphocellulose filter. Plates are then washed three times with 100 μL of H2PO4 (75 mM) filtered by a MultiScreen filtration system, and dried. After the additon of 100 μL of Microscint 0, radioactivity is counted in the TopCount. IC50 values are obtained by nonlinear regression analysis.
细胞实验
Cells are seeded into 96- or 384-wells plates at final concentration ranging from 1 × 104 to 3 × 104 per cm2. After 24 hours, cells are treated using serial dilution of PHA-793887. At 72 hours after the treatment, the amount of cells are evaluated using the CellTiter-Glo assay. IC50 values are calculated using a sygmoidal fitt(Only for Reference)
别名PHA793887, PHA 793887
化学信息
分子量361.48
分子式C19H31N5O2
CAS No.718630-59-2
SmilesCC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C
密度1.176 g/cm3 (Predicted)
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
Ethanol: 67 mg/mL (185.3 mM)
DMSO: 55 mg/mL (152.15 mM), Sonication is recommended.
H2O: < 1 mg/mL (insoluble or slightly soluble)
溶液配制表
1mg5mg10mg50mg
1 mM2.7664 mL13.8320 mL27.6640 mL138.3202 mL
5 mM0.5533 mL2.7664 mL5.5328 mL27.6640 mL
10 mM0.2766 mL1.3832 mL2.7664 mL13.8320 mL
20 mM0.1383 mL0.6916 mL1.3832 mL6.9160 mL
50 mM0.0553 mL0.2766 mL0.5533 mL2.7664 mL
100 mM0.0277 mL0.1383 mL0.2766 mL1.3832 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy PHA-793887 | purchase PHA-793887 | PHA-793887 cost | order PHA-793887 | PHA-793887 chemical structure | PHA-793887 in vivo | PHA-793887 in vitro | PHA-793887 formula | PHA-793887 molecular weight